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Abstract 
In interphase eukaryotic cells, almost all heterochromatin is located adjacent to the nucleolus or 
to the nuclear lamina, thus defining Nucleolus-Associated Domains (NADs) and Lamina–
Associated Domains (LADs), respectively. Here, we determined the first genome-scale map of 
murine NADs in mouse embryonic fibroblasts (MEFs) via deep sequencing of chromatin 
associated with purified nucleoli. We developed a Bioconductor package called NADfinder and 
demonstrated that it identifies NADs more accurately than other peak-calling tools, due to its 
critical feature of chromosome-level local baseline correction. We detected two distinct classes 
of NADs. Type I NADs associate frequently with both the nucleolar periphery and with the 
nuclear lamina, and generally display characteristics of constitutive heterochromatin, including 
late DNA replication, enrichment of H3K9me3 and little gene expression. In contrast, Type II 
NADs associate with nucleoli but do not overlap with LADs. Type II NADs tend to replicate 
earlier, display greater gene expression, and are more often enriched in H3K27me3 than Type I 
NADs. The nucleolar associations of both classes of NADs were confirmed via DNA-FISH, 
which also detected Type I but not Type II probes enriched at the nuclear lamina. Interestingly, 
Type II NADs are enriched in distinct gene classes, notably factors important for differentiation 
and development. In keeping with this, we observed that a Type II NAD is developmentally 
regulated, present in MEFs but not in undifferentiated embryonic stem (ES) cells.  
  
Introduction 
In eukaryotic cell nuclei, genomic loci are distributed in three-dimensional space in a non-
random manner. In particular, heterochromatic regions frequently reside at the nuclear lamina 
(NL) and/or in the perinucleolar region (van Koningsbruggen et al. 2010; Németh et al. 2010; 
Kind et al. 2013; Ragoczy et al. 2014; Kind et al. 2015). Loci clustered in these regions are 
generally less transcriptionally active and display histone modification patterns characteristic of 
poorly transcribed genes (reviewed in (Politz et al. 2013)). A major question in eukaryotic cell 
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biology is how non-random localizations of loci are achieved and how they foster functional 
sequestration or, conversely, how interactions among accessible regions are co-regulated 
(Schoenfelder et al. 2009). Multiple studies suggest that positioning of human cell 
heterochromatin to either the lamina of perinucleolar region appears to be stochastic, and 
reshuffled at each mitosis when chromosomes are condensed and then decondensed in the 
subsequent interphase (van Koningsbruggen et al. 2010; Kind et al. 2013). Heterochromatin 
interactions are also regulated during cellular differentiation (Peric-Hupkes et al. 2010; 
Meuleman et al. 2013). These long-range chromosome interactions in mammalian cells are of 
great interest because they can regulate the developmental timing (Vernimmen et al. 2007) or 
the variegation of gene expression (Noordermeer et al. 2011). However, mechanisms governing 
these dynamics remain poorly understood.  
As the site of ribosome biogenesis, nucleoli are organized around rDNA repeats (McStay 
and Grummt 2008; Pederson 2011) and consist of liquid-phase separated and functionally 
distinct layers of proteins and RNAs (Brangwynne et al. 2011; Feric et al. 2016). The 
perinucleolar chromatin that is the subject of this work surrounds nucleoli. This perinucleolar 
localization is a functionally relevant example of heterochromatin-mediated silencing, because 
transgene proximity to mammalian nucleoli is correlated with gene repression (Fedoriw et al. 
2012b). An important step for analysis of the relevant silencing mechanisms is deep sequencing 
of nucleolar-associated DNA. To date, this has been analyzed in human cells and the plant 
Arabidopsis thaliana (van Koningsbruggen et al. 2010; Németh et al. 2010; Dillinger et al. 2017; 
Pontvianne et al. 2016), and these studies have detected specific nucleolar-associated domains 
(NADs). Consistent with their heterochromatic status, NADs are enriched in the H3K9me3 
histone modification characteristic of constitutive heterochromatin, frequently include large 
multigene clusters, and are correlated with low gene expression and density.  
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Dramatic changes in the architecture of nucleolar-associated satellite DNA repeats during 
mouse development (Aguirre-Lavin et al. 2012) have been noted, but systematic 
characterization of murine NADs had not previously been done. To lay the groundwork for 
studying the biological roles of NADs in a system that allows analysis of mammalian 
developmental processes, we have mapped the nucleolar-associated domains (NADs) in 
mouse embryonic fibroblasts (MEFs). Also, previous studies of human NADs have differed 
regarding use of formaldehyde crosslinking and cell lines used (van Koningsbruggen et al. 
2010; Németh et al. 2010; Dillinger et al. 2017). Notably, direct tests of the effects of 
crosslinking have not been performed. Therefore, we directly tested the effects of crosslinking, 
which we found had small effects on NAD identification, indicating that heterochromatin is 
naturally tightly associated with nucleoli. As expected, the majority of NADs are also LADs, and 
we refer to these here as Type I NADs. However, we detected a subset of mouse NADs that are 
not preferentially associated with the nuclear lamina. Therefore, these analyses have identified 
a distinct Type II subset of NADs. Compared to the Type I NADs, the Type II subset displays 
greater levels of gene expression and H3K27me3 modification, earlier DNA replication timing, 
and is enriched for particular classes of genes. Additionally, we show via DNA-FISH analyses 
that a Type II NAD in MEFs is indeed not enriched at the nucleolar periphery in ES cells, 
indicating regulation during differentiation. Therefore, the methods and data presented here 
demonstrate a subset of nucleolar heterochromatin that is not easily explained by stochastic 
positioning. Further, this work provides a platform for future investigation of the dynamics of the 
nucleolar heterochromatic compartment.  
 
Results 
Isolation of nucleoli from crosslinked and non-crosslinked MEFs. For our initial analyses of 
murine NADs, we compared nucleoli prepared with or without formaldehyde crosslinking (Fig. 
1A; Supplemental Fig.1A). Both methods yielded highly-purified nucleoli based on phase 
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microscopy images (Supplemental Fig. 1B; see also the “NAD-seq” QC files at the NIH 4DN 
Data Portal (data.4dnucleome.org)). Quantitative PCR suggested that rDNA sequences were 
enriched relative to the input total genomic DNA > 20-fold in the non-crosslinked preparations, 
and > 7-fold in crosslinked preparations (Supplemental Fig. 1C). Immunoblot analyses showed 
enrichment of nucleolar protein fibrillarin relative to non-nucleolar proteins such as actin, a 
nucleoporin (Nup62), or lamin A/C (Supplemental Fig.1D). Additionally, we characterized the 
small RNAs present in the non-crosslinked preparation, observing that the nucleoli were highly 
enriched for the nucleolar U3 RNA (Supplemental Fig.1E). Small RNAs could not be recovered 
from crosslinked samples (data not shown).  
 
Bioinformatic analysis of nucleolar-associated DNA. We performed three biological replicate 
experiments for both the crosslinked and non-crosslinked protocols. For each experiment, we 
purified DNA from the isolated nucleoli, alongside genomic DNA from a sample of whole, 
unfractionated cells from the same population for normalization of the nucleolar sequencing 
data. These DNAs were used to generate sequencing libraries via PCR-free protocols, yielding 
genome-scale maps. Visual inspection of these “NAD-seq” data showed that the total genomic 
DNA was largely evenly distributed across the genome (Fig. 1B, C), occasionally interspersed 
with short, poorly represented regions. The nucleolar DNA was distributed with distinct peaks 
and valleys. The ratio of nucleolar/genomic read counts provides a raw metric of enrichment of 
nucleolar association.  
 We expected mouse nucleolar-associated regions to be highly enriched in 
heterochromatin, as observed in human cells (van Koningsbruggen et al. 2010; Németh et al. 
2010; Dillinger et al. 2017). Therefore, we compared our raw data to datasets that distinguish 
mouse euchromatin and heterochromatin. For example, late DNA replication (Hiratani et al. 
2008; 2010) and association with the nuclear lamina (Peric-Hupkes et al. 2010) are properties 
generally associated with heterochromatin (these features are colored red in Figs. 1B-C). 
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Notably, peaks in our raw nucleolar-associated DNA sequence data frequently overlapped 
these features. Additionally, we observed that the patterns of nucleolar enrichment often 
appeared similar in each of the triplicate experiments performed with the crosslinked (XL) and 
non-crosslinked (nonXL) protocols (Supplemental Fig. S2). Consistent with those profiles, 
Pearson correlation analysis of the nucleolar/genomic ratios from each of the six experiments 
displayed a high degree of similarity between crosslinked and non-crosslinked data 
(Supplemental Figure S2). Together, these data suggested that both of our biochemical 
preparation methods reproducibly yield mouse nucleolar heterochromatin. 
 To facilitate comparisons to other genomic features, we then sought to call peaks in our 
datasets, and tested several established bioinformatic packages developed for analysis of LADs 
or ChIP-seq data (Fig. 1B-C, Supplemental Fig. 3). We tested MACS, which is frequently used 
for the analysis of ChIP-Seq data (Zhang et al. 2008; Feng et al. 2012). Because of the large 
size of heterochromatin regions like NADs and LADs compared to most transcription factor 
binding sites, we also tested EDD (Lund et al. 2014), hidden domains (Starmer and Magnuson 
2016), and normr (Kinkley et al. 2016; Helmuth et al. 2016), packages suited for detecting 
enrichments over large genomic regions. We tested each of these using at least two different 
settings (Fig. 1 and Supplemental Fig. 3). Small chromosomes, which are more frequently 
associated with nucleoli (Quinodoz et al. 2018), were often annotated as almost entirely 
nucleolus associated using these tools (e.g. chr19, Fig. 1B), without distinguishing most peaks 
and valleys observed in the nucleolar DNA sequencing data. Conversely, we observed that for 
longer chromosomes, most of these packages identified very few peaks on the chromosome 
end distal from the centromere (pictured on the right side of these acrocentric mouse 
chromosomes, e.g. chr5 in Fig. 1C). We noted that the nucleolar/genomic ratios displayed a 
notable slope across large chromosomes, with higher average ratio values near the centromere-
containing end of the acrocentric mouse chromosomes. This likely reflects the frequent 
nucleolar association of pericentric heterochromatin (Ragoczy et al. 2014). However, even in 
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regions far from the centromeres, there are still local peaks in the nucleolar/genomic ratio, often 
coinciding with heterochromatic features. These observations suggested that normalizing data 
to a local background would facilitate accurate identification of peaks in regions that are not 
near centromeres on larger chromosomes, while also facilitating discrimination between peaks 
and valleys on small chromosomes.  
 Therefore, we developed a Bioconductor package termed NADfinder to analyze our data 
that includes local baseline correction (Supplemental Figure 4A-C and Material and Methods). 
We note that local baseline correction was required for the NADfinder program to identify peaks 
distal to the centromere. That is, without local baseline correction, only few strong peaks near 
the centromere-proximal end of the chromosome were identified (green tracks, Supplemental 
Fig. 4B, C), reminiscent of the stronger centromere-proximal peaks in the raw data (Fig. 1C). In 
contrast, inclusion of the baseline correction step generated peak profiles that are distributed 
across the chromosomes (blue tracks, Supplemental Fig. 4B, C). Notably, these baseline-
corrected peaks frequently overlap with lamin-associated regions and late replicating regions 
(red, Supplemental Fig. 4B, C), consistent with our expectation that NADs are largely 
heterochromatic.  
 In the first biological replicate experiment for each purification method, we sequenced 
approximately 200 million reads. To determine whether this amount was necessary, we 
performed preliminary peak calling using NADfinder, and then performed subsampling analyses 
(Supplemental Fig. 4D, E). Subsampling analysis results showed that the % of peaks detected 
and overlapped with those from the whole dataset initially increases quickly with increased 
depth of sequencing, and plateaus at a subsampling depth of approximately 25% (i.e. 50 million 
reads). We therefore performed 50 million reads for samples in the subsequent second and 
third replicate experiments for both experimental protocols (crosslinked (“XL”) and non-
crosslinked (“nonXL”)). We designed NADfinder with functionality for analyzing datasets with 
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biological replicates and for generating adjusted p-values for each peak. We used this feature to 
generate the preliminary “NADfinder” tracks shown in Fig. 1 and Supplemental Fig. 3.  
 
Distinct subsets of nucleolar-associated domains. In addition to MEF LADs (Guelen et al. 2008; 
Peric-Hupkes et al. 2010), we analyzed the “constitutive interLADs” (ciLADs), which are 
sequences that are not lamin-associated at any stage during neural differentiation of mouse 
embryonic stem cells, first into neural precursor cells and then astrorocytes (Peric-Hupkes et al. 
2010; Meuleman et al. 2013). That is, ciLADs generally represent euchromatic regions that 
display much higher levels of gene activity than do LAD regions. To analyze the overlap among 
NADs, LADs and ciLADs, we separated each nucleotide of our NAD peaks into subsets of those 
overlapping with one of the other datasets, or neither. For example (chr17, Fig. 2A), NADs (blue 
bars) and LADs (red) displayed frequent regions of overlap (magenta), in both the XL and 
nonXL datasets. Analysis of the overlaps in a genome-wide fashion (Fig. 3B), indicated that the 
majority but not all NAD peak sequences overlap with LADs, regardless of the nucleolus 
purification method. For example, ciLADs (Fig. 2A, cyan) overlap with a subset of NADs (green). 
The ciLAD-overlapped subset was smaller than the LAD-associated regions, but occurred in 
similar regions in samples from the two experimental protocols (XL and nonXL). Thus, we had 
subdivided NADs into LAD-overlapped and ciLAD-overlapped subsets. For convenience, we will 
refer to these as Type I and Type II, respectively. Additionally, a subset of NADs overlapped 
with neither LADs nor ciLADs (Fig. 2B). 
 We next compared NADs in our XL and nonXL datasets. Genome-scale analysis 
showed that almost all peaks in the nonXL dataset were also found in the XL dataset. 
Additionally, crosslinking resulted in a greater proportion of the genome identified as NAD peaks 
(Fig. 2C). Specifically, the NAD peaks comprised a total of 1137 Mb in the XL and 811 Mb in the 
nonXL datasets, representing 41% and 30% of the non-repetitive mouse genome, respectively. 
For comparison, LADs comprise approximately 40% of the mouse genome (Guelen et al. 2008; 
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Peric-Hupkes et al. 2010), and NADs in human diploid IMR90 fibroblasts cover 38% of genome 
(Dillinger et al. 2017). Also, XL and nonXL murine NADs had similar median lengths (Fig. 2D), 
comparable to MEF (534kb) and human fibroblast LADs (553kb) (Guelen et al. 2008; Peric-
Hupkes et al. 2010). Therefore, the overall characteristics of mouse NADs are similar to those of 
other large heterochromatic domains. However, as shown below, these genome averages mask 
distinct subsets within the population of mouse NADs. 
 
Immuno-DNA FISH validation of genomic data. To validate peaks called by NADfinder, we 
performed DNA fluorescent in situ hybridization (DNA-FISH) experiments. We used bacterial 
artificial chromosome (BAC) probes to detect specific genomic loci, and anti-fibrillarin or anti-
nucleophosmin antibodies to visualize nucleoli. We performed at least three biological replicate 
experiments per probe, scoring the percentage of alleles (n > 100) in a population of cells 
associated with nucleoli (Fig. 3A-C). First, we chose a negative control BAC (termed pPK871) 
that does not contain nucleolus-enriched sequences in either the crosslinked or non-crosslinked 
data (Supplemental Fig. 5A). As expected, we observed a low frequency of overlap between 
pPK871 and nucleoli (median value of 14% of alleles scored, Fig. 3D), similar to the values 
observed for non-nucleolar associated probes in human cell studies (van Koningsbruggen et al. 
2010; Németh et al. 2010; Smith et al. 2014; Dillinger et al. 2017). We analyzed multiple 
additional probes to characterize NAD associations in MEFs (e.g. Figs. 3B, C; Supplemental 
Figure S5), and observed that probes from both “Type I” and “Type II” NAD peaks displayed 
significantly greater frequencies of association with nucleoli than did pPK871. This was evident 
in the measurement of the percentage of total alleles associated for the individual probes 
analyzed (Fig. 3D), and when data for the probes of each group were combined (Fig. 3E). 
Additionally, we compared the observed percentage of nucleolar association of FISH probes to 
the adjusted p-value (q value) of the corresponding peaks calculated by NADfinder (Fig. 3F-G). 
For both the nonXL and XL datasets, we observed high q values for “negative” probes which 
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displayed nucleolar association levels statistically indistinguishable from those of negative 
control pPK871 (Fig. 3F-G, colored in blue). In contrast, the Type I (green) and II (red) NAD 
probes displayed lower q values, clearly distinct from the negative probes (note that the x-axis in 
these graphs is logarithmic). We conclude that NADfinder identified bona fide NADs.  
 
Testing association of NADs with the nuclear lamina. Designation of Type II NADs was based 
on overlap with ciLAD regions, which do not associate with the nuclear lamina in MEFs or 
during neural differentiation of ES cells (Peric-Hupkes et al. 2010; Meuleman et al. 2013). 
However, we considered the possibility that some regions could have been classified as type II 
NADs if their apparent lack of laminar association was a false negative. We therefore directly 
tested a subset of our BAC probes for associations with the nuclear lamina in additional 
immunoDNA-FISH experiments. In this case, we tested for colocalization with the edge of DAPI-
stained material, which can be highlighted by staining with antibodies against a nuclear pore 
protein (Fig. 3H-I). We observed that our negative control BAC, pPK871, displayed on average 
~20% association with the lamina, whereas a Type I probe that overlaps with a LAD, pPK834, 
displays significantly higher association frequencies (Fig. 3J). In contrast, three different Type II 
probes displayed frequencies of lamina association that were not significantly different from 
those of the negative control. These data indicate that Type II NADs are a subset of 
heterochromatin that preferentially associates with nucleoli rather than the nuclear lamina in 
MEF cells. 
 
Biological properties of the NAD subsets. To explore NAD biological properties, we first 
compared gene densities of different NAD subsets to the rest of the genome (Fig. 4A). 
Consistent with their heterochromatic character, the complete sets of NADs identified by either 
the XL and nonXL protocols (red bars) display much lower average gene density than the 
genome average (brown). Furthermore, LAD-overlapping Type I NADs (pink bars), display even 
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lower gene density levels. In contrast, the ciLAD-overlapped Type II NADs (purple bars) display 
greater gene densities than do Type I NADs, NADs that overlap with neither LADs nor ciLADs, 
or NADs as a whole. Next, we examined steady-state RNA levels in the different classes, 
expressed as FPKM in RNAseq data (Fig. 4B). We observed that NADs are much less frequent 
sites of gene expression than the genome-wide average. However, the Type II NADs are 
distinct in that they display elevated gene expression compared to the other subclasses, 
consistent with the euchromatic character of the ciLAD subset of the genome (Meuleman et al. 
2013). In summary, these data indicate that NADs are not solely heterochromatic. 
 We next examined DNA replication timing (Fig. 4C-F), a genomic feature that largely 
distinguishes euchromatin and heterochromatin (Hiratani et al. 2008; 2010). We focused on the 
regions of overlap between the replication timing (RT) data and the NAD peaks (numbered 
regions in Fig. 4C-F). We note that these are representative of the genome-wide trends, but the 
absolute values are smaller than other overlaps we analyzed (e.g. Fig. 2B), because the RT 
data peaks consist of short microarray probes. We observed that NAD regions overlapping with 
early RT were more likely to also overlap with ciLADs (0.52 Mb) than LADs (0.30 Mb; Fig. 4C-
D). A much more skewed distribution was observed for the late RT-NAD overlapped regions, 
which displayed a ten-fold larger overlap with LADs than ciLADs (Fig. 4E-F). Therefore, the 
LAD-overlapped Type I NADs are almost always late replicating; Type II NADs are distinct with 
their tendency towards early replication. 
 We then analyzed histone modifications related to heterochromatin, namely H3K9me3, a 
hallmark of constitutive heterochromatin that is generally inaccessible to transcription factors, 
and H3K27me3, a hallmark of facultative heterochromatin that is frequently regulated in a 
tissue-specific manner and is accessible to transcription factors and paused RNA polymerase 
(Becker et al. 2016). We observed that just under half of NAD regions overlapping with LADs 
(Type I NADs) also overlapped with H3K9me3 peaks (261 Mb of 542 Mb, Fig. 4G), while a 
smaller proportion (185 of 542 Mb) overlapped with H3K27me3 peaks (Fig. 4H). These data are 
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consistent with the extensive H3K9me3 marking across LADs (Sadaie et al. 2013), which also 
feature less broad H3K27me3 peaks at their boundaries (Guelen et al. 2008; Harr et al. 2015). 
A more dramatic difference was observed upon inspection of the NAD-ciLAD overlapped 
regions (Type II NADs) (Fig. 4I-J). Only 37 Mb out of these 134 Mb overlapped H3K9me3 peaks 
(Fig. 4I), but twice as much (74 Mb) overlapped H3K27me3 peaks (Fig. 4J). Thus, compared to 
Type I NADs, Type II NADs lack lamin association, display greater gene density, expression, 
and H3K27me3 marks, and are more often early replicating. Thus, the Type II subset of NADs 
shares many features with facultative heterochromatin.  
 
 Roles of H3K27 methylation and phase separation. A hallmark of facultative 
heterochromatin is methylation of histone H3K37 by the Ezh2 subunit of the Polycomb 
Repressive Complex 2 (PRC2, (Margueron and Reinberg 2011)). Previous studies implicated 
H3K27me3 in the localization of LADs to the nuclear periphery (Harr et al. 2015), so we tested 
whether the same would be true for nucleolar localization. Using two commercially available 
inhibitors of the Ezh2 methyltransferase, we observed that we could efficiently reduce cellular 
H3K27me3 levels, detected either via immunofluorescence or immunoblotting (Fig. 5A-E). Both 
these compounds significantly reduced both the nucleolar and the laminar association of Type I 
BAC probe, pPK834 (Figure 5F-J). Analysis of a Type II probe (pPK828) showed significant loss 
of nucleolar association in the presence of EPZ6438; the inhibitor GSK126 reduced association 
but not to a statistically significant level (Fig. 5K-O). pPK828 does not associate above 
background levels with the nuclear lamina, and neither drug altered that pattern. Together, 
these data indicate that H3K27 methylation is important for both nucleolar and laminar 
heterochromatic localizations.  
 Recent data indicate that higher order chromosomal interactions can be driven by phase 
separation, involving liquid demixing of heterochromatin components (Strom et al. 2017; Larson 
et al. 2017). Phase separation also contributes to the self-assembly of nucleoli themselves 
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(Feric et al. 2016). One diagnostic used to study these compartmentalized interactions is the 
sensitivity of these to the aliphatic alcohol 1,6-hexandiol, which is thought to perturb liquid-like 
condensates via disruption of weak hydrophobic interactions (Ribbeck and Görlich 2002). We 
therefore tested whether features of MEF heterochromatin would also be sensitive to this 
compound. First, we observed that the pattern of H3K9me3 localization, which prominently 
decorates punctate foci of heterochromatin in untreated MEF cells (Guenatri et al. 2004; Michal 
Sobecki et al. 2016), was dramatically relocalized upon incubation of cells in media containing 
1% hexanediol for two hours (Fig. 5P-Q). These data are consistent with large-scale 
heterochromatin alterations. We also noted that nucleoli themselves were still present, and that 
the 1% hexanediol concentration tested is below that used to disrupt other liquid demixed 
entities, such as the nematode synaptonemal complex (Rog et al. 2017), Drosophila HP1 
clusters (Strom et al. 2017), yeast or human cell stress granules (Kroschwald et al. 2015; 2017),  
or nuclear pore complexes (Ribbeck and Görlich 2002). We therefore tested whether NAD 
interactions with nucleoli were affected by hexanediol after two hours of treatment. We observed 
a dose-dependent response, with a significant loss of nucleolar association of NADs at 1% 
hexanediol (Fig. 5R). These data suggest that NADs are a phase-separated form of 
heterochromatin.  
 
 Type II NADs house developmentally regulated genes. In order to learn more about the 
potential for gene expression from type II NADs, we tested for enrichment of GO-terms among 
the genes in these regions (Fig. 6A-C; Supplemental Tables 2-3). Within the “Biological 
Processes” classifications, we observed the lowest adjusted p-values are for terms associated 
with developmental processes, for example organ morphogenesis and sensory organ 
development. Individual genes within these categories included the developmental transcription 
factors Pax2 (Fig. 6D) and Sox1 (Fig. S6A), and developmental signaling molecules such as 
Fgf1 (Fig. S6B) and Bmp4. Most notable among the “Cell Components” GO terms were keratin 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/484568doi: bioRxiv preprint first posted online Dec. 3, 2018; 
	 14 
intermediate filament proteins, which can occur in gene clusters within a NAD (Fig. S6C). In 
addition, multiple types of ion channels were detected such as Scn sodium channel genes (Fig. 
S6C). The most significant GO-derived “Molecular Functions” classes included transcription 
factors; other classes include solute transporters such as glutamate transporter Grik3 (Fig. 6E).  
In summary, these data indicate that a distinct subset of transcription factors related to 
differentiation, and hallmarks of differentiated cell lineages including ion channels, are enriched 
within the Type II NADs in MEF cells.  
 The observation that Type II NADs contain many developmentally regulated genes 
raised the question of whether there is developmental regulation of perinucleolar 
heterochromatic associations. As a first test of this idea, we performed DNA-FISH experiments 
using D3 mouse embryonic stem cells (Hiratani et al. 2010)(Fig. 6F-H). As we observed in MEF 
cells, the negative control BAC pPK871 displayed low levels of nucleolar association, and Type 
I probe pPK834 was significantly more frequently associated. In contrast, Type II probe pPK828, 
which was associated with nucleoli but not lamina in MEF cells (Figures 2-3), was not 
significantly nucleolar associated in D3 cells. These data indicate that NADs can adopt different 
localizations in different cell types.   
 
Discussion 
NADfinder, a new Bioconductor package for large domain analysis.  
 In previous studies of NAD sequences (Németh et al. 2010; van Koningsbruggen et al. 
2010; Dillinger et al. 2017; Pontvianne et al. 2016), bioinformatics tools for analyzing these 
datasets had not been developed. We found that tools developed for analyzing LADs and ChIP-
seq data were suboptimal for the analysis of the mouse NADs. Specifically, multiple existing 
software packages failed to detect NADs in the regions distal to the centromere in long 
chromosomes and/or would label almost the entire short chromosomes as NADs in our MEF 
dataset (Figs. 1 and S3). We therefore developed a Bioconductor package called NADfinder. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/484568doi: bioRxiv preprint first posted online Dec. 3, 2018; 
	 15 
We observed that the use of local baseline correction enhanced recognition of peaks in the 
distal regions of large chromosomes, while improving the distinction of peaks on small 
chromosomes (Fig. S4). Importantly, peaks called by NADfinder were validated via DNA-FISH 
experiments (Fig. 3). We imagine that NADfinder will not only be useful for NAD studies, but will 
be globally useful for the analysis of large chromosome domains, particularly in cases where 
local background signals will differ significantly across the genome.  
 One advantage of deploying our software in the Bioconductor framework is that we can 
leverage the rich genomic annotation data and borrow functionalities already implemented in 
other R/Bioconductor packages. For example, we used the ATACseqQC package (Ou et al. 
2018a) to efficiently read in the alignments, the baseline package for baseline correction, the 
signal package for smoothing, the trackViewer package (Ou et al. 2018b) for visualizing the 
signals, the limma package (Ritchie et al. 2015) for statistical analysis of the signal noise ratios 
across multiple replicates, and the ChIPpeakAnno package (Zhu et al. 2010; Zhu 2013) for 
annotating NADs with other genomic features of interest and for GO enrichment analyses. 
NADfinder is freely available at 
https://bioconductor.org/packages/release/bioc/html/NADfinder.html. Major functions are 
described in the Material and Method section. More detailed information on the commands and 
instructions for running the software are included in the associated user guide at 
https://bioconductor.org/packages/release/bioc/vignettes/NADfinder/inst/doc/NADfinder.html 
and https://bioconductor.org/packages/release/bioc/manuals/NADfinder/man/NADfinder.pdf. 
 
 Diverse classes of perinucleolar heterochromatin. Previous studies in human cells 
suggested that there should be extensive overlap among LAD and NAD regions of the genome. 
Specifically, several experiments revealed extensive reshuffling of the interphase localizations 
of heterochromatin during each mitosis. For example, in an interphase cell, photoactivation of 
caged fluorescent histones near the nucleolar periphery results in the labeled molecules being 
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distributed both at the nucleolar periphery and at the lamina in the two daughter cells after 
mitosis (van Koningsbruggen et al. 2010). Likewise, imaging of a GFP-DamID reader domain 
protein showed that LADs redistribute not only to lamina but also to nucleoli in daughter cells 
(Kind et al. 2013). These experiments indicated that the interphase localization of 
heterochromatin is largely stochastic, with apparent random placement of heterochromatic loci 
either at the lamina or surrounding nucleoli. Therefore, the expectation was that LADs and 
NADs would be largely the same.  
 Previous mapping of nucleolar heterochromatin has been done in human cells and in the 
plant Arabidopsis (Németh et al. 2010; van Koningsbruggen et al. 2010; Dillinger et al. 2017; 
Pontvianne et al. 2016). In human cells, the pioneering studies first describing perinucleolar 
heterochromatin (Németh et al. 2010; van Koningsbruggen et al. 2010) had low sequencing 
depth by today’s standards, but generally supported the idea that NADs are heterochromatic, 
with reduced gene density and expression relative to the genomic average. More recently, 
analysis of human IMR90 fibroblast heterochromatin emphasized the overlap and similarity 
between NADs and LADs, sharing enrichment for H3K9me3, gene and repeat density (Dillinger 
et al. 2017). In summary, the cell biological and genomic experiments mentioned above 
indicated that the majority of mammalian heterochromatin is directed in a stochastic manner to 
either the lamina or the perinculeolar region. 
 However, there have also been experiments suggesting that there are trans-acting 
factors that can specifically regulate particular heterochromatin destinations. For example, the 
lamin B receptor, an integral protein of the inner nuclear membrane, contributes to the laminar 
association of heterochromatin (Solovei et al. 2013). Conversely, the Chromatin Assembly 
Factor-1 p150 subunit governs the nucleolar localization of proliferation antigen Ki-67, which in 
turn governs NAD localization to nucleoli (Smith et al. 2014; Matheson and Kaufman 2017). The 
specificities observed in these studies suggest that not all heterochromatic loci will localize 
stochastically, and that some recruitment to specific locations can occur.  
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 We also note that a recent study showed that an Ezh2-containing ribonucleoprotein 
complex termed MICEE tethers specific loci to the perinucleolar region (Singh et al. 2018). 
However, Ezh2 appears to have multiple roles, because inhibition of H3K27me3 inhibits both 
laminar {Harr:2015gj and nucleolar heterochromatin localizations (Fig. 5). Indeed, the latter data 
suggest that H3K27me3 could have a crucial and general role in heterochromatin localization, 
perhaps via contributing to phase separation (Fig. 5). However, there are likely to be multiple 
mechanisms, because the PRC2 complex that catalyzes H3K27me3 is not required for 
nucleolar localization of the Kcnq1 locus (Fedoriw et al. 2012a). 
 In summary, our data indicate that a significant subset of nucleolar heterochromatin is 
not frequently distributed to the lamina. Specifically, through locus-unbiased biochemical 
purification of nucleoli based on their sedimentation properties and resistance to sonication, we 
found distinct classes of loci in the associated DNA. The majority of NADs identified (Fig. 2B) 
were the expected loci that overlap with LADs, which we term Type I NADs here. However, we 
also identify Type II NADs, which were defined as peaks in our data that overlap with regions 
previously classified as “ciLAD”, that is, regions that do not associate with lamina at multiple 
stages of cellular differentiation (Peric-Hupkes et al. 2010; Meuleman et al. 2013). We 
hypothesize that Type II NADs will be enriched in sites of regulated localization and expression 
during differentiation, and we are now testing these ideas.  
 We note other recent studies have shown that sedimentation behavior of short cross-
linked chromatin fragments helps detect functionally distinct subpopulations that cannot be 
distinguished by histone modification patterns alone (Becker et al. 2017). Therefore, we believe 
that biochemical studies can serve as an important alternative source of data for analyzing the 
structure and function of mammalian genomes.  
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Materials and Methods 
 
Cell culture and treatments. Mouse embryonic fibroblasts (MEFs) derived from C57/Bl6 mice 
were immortalized using a standard 3T3 procedure (Todaro and Green 1963) at the UMASS 
Transgenic Mouse Modeling Core. Cells were obtained at p48. Cells were cultured in 
Dulbecco`s modified Eagle medium, DMEM (Life technologies, cat#11995-065), 10% bovine 
fetal serum, and 100 U/ml penicillin/ streptavidin. For passaging, old medium was aspirated, and 
cells were washed with 5 ml PBS per 10 cm plate. 1 ml of 0.05% (w/v) trypsin-EDTA was added 
and the plate was incubated at 37°C until the cells detached. 5 ml 37°C medium was added per 
10 cm plate to quench the trypsin and the cells were transferred to a 15-ml conical tube and 
pelleted by centrifugation for 5 min at 200g at 4°C. Media was aspirated and cells were 
resuspended in 5 ml of fresh pre-warmed (37°C) medium. Cells were passaged at dilutions 
ranging from 1:2 to 1:10.  
  
MEF cells were cloned by serial dilution. Cells diluted into single cell per well in 96-well plates, 
and wells containing healthy single clones were further expanded. Of these, Clone 5 cells were 
used in all experiments except uncrosslinked nucleolus isolation experiment #18 (see 
Supplemental Table S1), which used the uncloned population. 
 
For Ezh2 inhibitor experiments, MEF cells were either treated with 0.1% DMSO or with the 
following inhibitors for 72 hours.  
 
Inhibitor  Cat. No.  Stock  Final conc 
GSK126 ApexBio #A3446 10 mM in DMSO 10 μM  
EPZ6438 ApexBio #A8221 10 mM in DMSO 100 nM 
 
1,6-Hexanediol (Sigma-Aldrich, #240117-50G) was dissolved directly into culture media (10% 
stock). MEFs were treated with a final concentration of 1% or 0.5% 1,6-Hexanediol for 2 hrs.  
Mouse embryonic stem cell (mES) line D3 was a kind gift from David Gilbert’s lab. The cells 
were grown in 2i mES medium on plates without gelatin coating, so that the cells grew in 
suspension. Below are components used for 2i mES medium: 
Serum free ES medium (SFES) - 1000 ml  
Solution (stock)  Cat. No.  Final conc.  Volume  
NEUROBASAL MEDIA  Gibco 21103-049  50%  500ml  
DMEM/F12  Gibco 11320-033  50%  500ml  
N2-SUPPLEMENT  Gibco 17502-048  0.5x  5ml  
B27(+RA)  Gibco 17504-044  0.5x  10ml  
7.5% BSA  Gibco 15260-037  0.05%  6.66ml  
Complete “2i” medium - 100 ml  
Solution (stock)  Cat. No.  Final conc.  Volume  
SFES  N/A  1x  100ml  
PD03259010 (10mM)  Reprocell 04-0006-02C  1 μM  10 μl  
CHIR99021 (10mM)  Reprocell 04-0004-02C  3 μM  30 μl  
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/484568doi: bioRxiv preprint first posted online Dec. 3, 2018; 
	 19 
GLUTAMINE (200mM)  Gibco 25030-081  2mM  1ml  
Monothioglycerol (11.9M)  Sigma M6145-25ML  1.5x10-4M  1.26 μl  
LIF (1x10^6 U/ml)*  Cell Guidance Systems GFM200   1,000U/ml  100 μl*  
Medium was kept out of the light at 4 ̊C, for no more than 2 weeks.  
Cells were passaged by removing “2i” media and applying 0.5 ml of accutase (EMD Millipore 
SF006) per 3 cm plate for a few minutes at RT to separate cell colonies and to obtain a single-
cell suspension. After incubation with accutase, 5 mL of SFES was added. The suspension was 
transferred into 15 ml tube and centrifuged at 1,000 rpm for 5 min at RT. The cell pellet was 
resuspended in complete “2i” media and plated into new vessel at a dilution of 1:6-1:10.   
MEF Nucleoli isolation. For each preparation, cells were grown in ten 15 cm plates until they 
reached 80-90% confluence, for a total of 30-100 x 106 cells. Old media was removed and fresh 
media was added 1 h prior to nucleoli preparation.  An additional plate grown in parallel was 
reserved for total genomic DNA extraction (Quick-DNA Universal Kit (Zymo Research, CA)).  
 
Non-crosslinked method of nucleoli isolation. The method was adapted from the Lamond lab 
protocol (van Koningsbruggen et al. 2010). Each dish was rinsed twice with 5 ml pre-warmed 
PBS, 3 ml 0.25% trypsin-EDTA were added per dish, followed by incubation at 37°C until cells 
were detached. 10 ml of complete media was added to each plate to quench the trypsin, and 
the cells were centrifuged in 50 ml conical tubes at 925 x rpm (200 x g) for 5 min (Sorvall 
Legend RT centrifuge) at 4°C. Cell pellets were washed with PBS and the packed cell volumes 
(PCV) were estimated. Five pellet volumes of PBS were added, cells were centrifuged and 
resuspended in ice-cold PBS, cell numbers were measured using a haemocytometer. At this 
point, the cells for the total genomic DNA sample were frozen. For the remainder of the cells, ~ 
3 x PCV of ice-cold Nuclear Extract Buffer A (10 mM Hepes-KOH, pH 7.9, 10 mM KCl, 1.5 mM 
MgCl2,), plus 0.5 mM DTT was added freshly. Cells were incubated on ice for 10 min to promote 
swelling in this hypotonic buffer. Swelling was monitored using a Evos microscope with a 20X 
objective, using the phase contrast filter. Swollen cells were transferred by pouring into a glass 
Wheaton Dounce homogenizer (15-ml size, pre-rinsed with Nuclear Extract Buffer A) with a 
Type B Pestle, pre-chilled on ice. Cells were homogenized with 30 slow strokes, and lysis was 
assessed by examination of a small aliquot on the Evos microscope. The homogenization was 
stopped when >90% of the cells were burst, leaving intact nuclei and with various amounts of 
cytoplasmic material attached. 0.1-0.5 ml was saved as a total extract sample. Homogenized 
cells were centrifuged at 2000 rpm for 5 min at 4°C. A 0.5 ml aliquot of the supernatant was 
saved as “cytosolic extract”. The crude nuclear pellet was resuspended with 3 ml solution S1 
(0.25 M sucrose, 10 mM MgCl2) and freshly added plus 0.5 mM DTT. Any pellet that could not 
be resuspended readily by gentle pipetting likely contained lysed nuclei and was discarded. 
Each resuspended pellet was layered over 4 ml of S2 (0.35 M sucrose, 0.5 mM MgCl2) solution 
in a 15-ml conical tube and centrifuged at 2000 rpm for 5 min at 4°C to enrich the purity of the 
nuclei. The purified nuclear pellets were then resuspended with 3 ml of S2 solution by gentle 
pipetting. A 0.1 ml sample of these resuspended nuclei was reserved as the “Nuclear” fraction. 
The nuclear suspension was sonicated with 10 second bursts (with 10 second intervals between 
each burst) using a Soniprep 150 (MSE) with a fine probe sonicator and set at power setting 5. 
The sonication was monitored using a phase contrast microscope. The sample was sonicated 
until almost no intact cells were detected and released nucleoli were observed as dense, 
refractile bodies. 0.7 ml of the sonicated sample was layered over 0.7 ml of S3 solution (0.88 M 
sucrose, 0.5 mM MgCl2) in 1.5 ml microfuge tubes and centrifuged at 20 seconds at 16,000 x g 
at 4°C. The pellet contains the nucleoli, and the supernatant (combining both the sucrose layer 
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and the upper aqueous material) was retained as the “nucleoplasmic fraction”. The nucleoli 
were resuspended with 1.0 ml of S2 solution, combined in one microfuge tube, followed by 
centrifugation at 1430 x g for 5 min at 4°C. This wash was repeated twice. The pellet contains 
highly purified nucleoli. The nucleoli were resuspended in 0.2 ml of S2 solution, snap frozen in 
liquid nitrogen and stored at –80 °C. 
 
Crosslinked method of nucleoli isolation. The preparation of formaldehyde-crosslinked cell 
extracts was adapted from previous studies (Németh et al. 2010; Sullivan et al. 2001). Cells 
were grown as above and fixed with 1% formaldehyde added directly to the media and 
incubated at RT. After 10 min, the media was removed and the crosslinking was quenched by 
adding 5 ml 1M glycine. The cells were washed with ice-cold PBS, collected by scraping in 40 
ml PBS, and centrifuged at 200 x g for 5 min at 4°C. The cell pellet was re-suspended in 1 ml 
high magnesium (HM) buffer (10 mM HEPES-KCl pH7.5, 0.88 M sucrose, 12 mM MgCl2, 1 mM 
DTT).  Cells were then sonicated on ice (2-3 bursts for 10s at full power) using a Soniprep 150 
(MSE) with a fine probe. The release of nucleoli was monitored microscopically. Nucleoli were 
pelleted by centrifugation in a microfuge at 15000g for 20s and re-suspended in 0.5 ml low 
magnesium (LM) buffer (10 mM HEPES-KCl pH 7.5, 0.88 M sucrose, 1 mM MgCl2, 1 mM DTT). 
The sample was subjected to a second round of sonication (1 burst 10s full power), and 
centrifuged at 15,000g for 20s to pellet nucleoli. The pellet was resuspended in 20/2 TE buffer 
(20 mM Tris-Cl pH 7.5, 2 mM EDTA) for immediate use or in 20/2TE + 50% glycerol to snap 
freeze in liquid nitrogen and store at -80°C. 
 
Quantitative PCR. DNA extraction from input whole cells and purified nucleoli was performed 
using Quick-DNA Universal Kit (Zymo Research, CA). DNA concentration was measured by 
Qubit dsDNA HS Assay kit (Invitrogen, Eugene, OR). 5 ng of DNA from each sample was 
analyzed using the Kappa Sybr Fast Q-PCR Kit (Kappa Biosystems, Wilmington, MA). The 
following primers were used: Set1 Fw: gag gtt gaa ggt ggt ttc ca; Rv: gag cag tcg ggt gct ctt ac; 
Set 2 Fw: gaa ctt tga agg ccg aag tg; Rv: atc tga acc cga ctc cct tt. The following program was 
used: 98°C 30s, 95°C 10s, 60°C 30s, 40 cycles. All the signals were normalized to that of 
genomic DNA as indicated in the figure legends, and the 2−ΔΔCT method was used for 
quantification (Life Technologies). 
 
Antibodies. The following antibodies were used: fibrillarin (ab5821, Abcam, Cambridge, MA), 
B23 (nucleophosmin) (sc-32256, Santa Cruz, Dallas, TX), Nup62 (ab50008, Abcam Cambridge, 
MA), Lamin A/C (2032, Cell Signaling technology, Danvers, MA USA), Lamin A (ab25300, 
Abcam), Nucleophosmin (ab10530, Abcam), Histone H3 (di methyl K9) (ab1220, Abcam), 
Histone H3 K9me3 (ab8889, Abcam), H3 K27me3 (39155, ActifMotif), Histone H3 (ab18521, 
Abcam), actin (sc-8432, Santa Cruz, Dallas, TX). Secondary antibodies for immunofluorescence 
were conjugated with: Alexa 488, Cy3 (Jackson ImmunoResearch, West Grove, PA). For 
western blots, horseradish peroxidase (HRP) anti-mouse and anti-rabbit secondary antibodies 
(Jackson ImmunoResearch, West Grove, PA) were used.  
 
Immunoblotting. Protein concentrations from total cell lysates or isolated nucleoli were assessed 
by Bradford assay (BioRad reagent Blue R-250, cat. #161-0436 with BSA as a standard). 10 μg 
of each sample were loaded per lane on 12% SDS-PAGE gels, transferred to PVDF membrane 
for 2hrs, 80v, 4°C. Membrane was blocked in PBS-nonfat milk and incubated with 
corresponding antibodies in accordance to manufacture instructions. 
 
Small RNA isolation.   Small RNAs were isolated using Qiagen miRNAeasy kits. In brief, we 
prepared RNA from 500 μl from each fraction that was collected during non-crosslinked nucleoli 
preparations. 700 μl QIazol reagent was added, and the mixture was vortexed and incubated at 
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RT for 5 min. After incubation, 140 μl of chloroform was added, vortexed, incubated for 2 min at 
RT and clarified by centrifugation for 15 min at 12,000g at 4° C. The aqueous clear phase was 
transferred in to new tube and 1.5x volume of 100% ethanol was added, mixed by pipetting, and 
loaded onto the RNAeasy column. Non-bound material was removed by centrifugation, and the 
column was washed with RPE buffer and eluted in 50 μl of RNAse-free water. 3 μl of RNAse 
inhibitor (Promega, N2511) was added to each sample. 1 μg of RNA from total, cytosolic, 
nuclear, nucleoplasmic and nucleolar fractions analyzed on a 10% denaturing 7 M urea 
acrylamide gel and stained with SybrGreen (Sigma-Aldrich, #S9305, 1:10,000 dilution).  
 
DNA isolation, deep sequencing, and read preprocessing and mapping. Total genomic and 
nucleolar DNA was isolated with Quick-DNA Universal Kit (Zymo Research, CA, USA). Libraries 
were constructed using Illumina`s TruSeq DNA PCR-free Library Preparation kit (350 bp) and 
fragments were size-selected by sample-purifying beads. 150bp paired-end sequencing was 
performed using Illumina HiSeq X Ten sequencing system using the HiSeq X Reagent Kit 
V2. 206.6 and 186.6 million reads for first replicate were obtained from genomic and nucleolar 
samples, respectively. >96% and >94%, respectively, of these were mappable. For subsequent 
samples, the subsampling analysis suggested that 50 million reads were sufficient 
(Supplemental Figure 3). For more details on sequencing, please see the files associated with 
the data at data.4dnucleome.org.  
 
Sequencing reads were trimmed with cutadapt (version 1.16) (Martin 2011) before being aligned 
to the mouse genome (mm10) using Bowtie2 v2.1.0 with the standard default settings 
(Langmead and Salzberg 2012). Alignments with mapping quality score greater than 20 were 
kept (samtools v1.3), and duplicated reads were removed using picard tools v1.96 
(hNps://broadinsUtute.github.io/picard/). To visualize the mapped reads, the bigwig files were 
generated using deepTools2 (Ramírez et al. 2016). 
 
NAD identification and annotation. To facilitate the analysis of this type of data, we implemented 
a common workflow for NAD-seq data analysis as a Bioconductor package called NADfinder.  
To make it easy to use, all the functionalities for analyzing data with multiple biological 
replicates have been wrapped into four functions: tileCount, log2se, 
smoothRatiosByChromosome and callPeaks. An overview of the NADfinder workflow is 
depicted in Supplemental Figure S4A. Briefly, summarized counts for each moving window 
(default 50kb) with a step size (default 1kb) are computed for nucleolar and genomic samples 
using the tileCount function. Log2 ratios of counts or CPM are computed between nucleolar and 
corresponding genomic samples for each window using the log2se function. Chromosome-level 
baseline correction and smoothing of Log2 ratios are performed using the function 
smoothRatiosByChromosome. Peaks/NADs across biological replicates are called, filtered and 
merged using callPeaks. We used default setting of NADfinder to analyze our data except the 
following parameter settings: lfc=log2(1.5), countFilter = 200 and cutoffAdjPvalue = 10-3 (10-2 for 
chrX, where the signal to noise ratio is less than other chromosomes). 
Nucleotide-level overlap analysis of NADs and other genomic features such as LADs, H3K9me3 
and H3K27me3 were performed using GenomicRanges (Lawrence et al. 2013). Specifically, the 
functions intersect and setdiff were used to obtain the overlapping nucleotides between two 
peak Granges, and the nucleotides in only one of the peak Granges, respectively. In addition, 
GO enrichment analysis of different classes of NADs were performed using ChIPpeakAnno 
(Zhu 2013; Zhu et al. 2010).  
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DNA-FISH probes. The bacterial artificial chromosomes (BACs) were obtained from the 
BACPAC Resource Center of Children’s Hospital Oakland Research Institute (Oakland, CA).  
DNA was isolated using BAC mini DNA prep Kit (Zymo Research, CA). BAC probes were and 
labeled using the Bioprime Labeling Kit (Invitrogen Eugene, OR USA).  
 
Laboratory BAC 
Probe 
Nomenclature 
Systematic 
BACPAC name 
Coordinates (GRCm38 
(mm10)) 
	pPK824 RP23-259J6  chr19: 8064943-8232607 
pPK825 RP23-444J20 chr17: 34211624-34393919  
pPK827 RP23-50O18 chr12: 114981697-115224299 
pPK828 RP23-103F12 chr12: 112224643-112423224 
pPK831 RP23-340I4 chrX: 116237263-116428250 
pPK832 RP23-129I12 chr2: 129216980-129424990 
pPK834 RP23-355A8  chr16: 44816053-45031327 
pPK871 RP23-322M3 chr12: 110758289-111006192 
pPK914 RP24-212E13 chr16: 95,182,165-95,358,805 
pPK915 RP23-3G4 chr17: 12,456,384-12,690,495 
 
 
3-D DNA FISH/ immunocytochemistry and microscopy. 
 
Immunofluorescence microscopy analysis of DNA-FISH/immunocytochemistry-labeled cells was 
carried out as previously described (Smith et al. 2014; Matheson and Kaufman 2017). Briefly, 
cells were grown on sterile coverslips until ~70% confluent. For mES cells, serum was added to 
2i medium (10% final) prior to seeding them on 0.1% gelatin-coated coverslips (10 hours). Cells 
were rinsed in PBS, placed in a coplin jar just long enough to rinse with 10 ml of CSK buffer 
(CSK Stock: 50 ml 0.1 M Pipes- NaOH pH 7.8; 50 ml 1M NaCl; 1.5 ml 1M MgCl2; 51.35 g 
sucrose. Total volume was brought to 500 ml with H2O, filter sterilized and stored at 4°C). Next, 
cover slips were transferred into a second coplin jar containing Triton-CSK buffer for 5 min (9 ml 
CSK buffer + 0.5 ml 10% TritonX-100 solution (Roche) + 0.5 ml 200 mM VRC (vanadyl 
ribonucleoside complex; NEB). After 5 min on ice, the samples were transferred into a third jar 
containing 10 ml of 4% Paraformaldehyde in 1X PBS for 10 min at RT. Samples were rinsed 
with RT 70% EtOH 3x, and transferred into a coplin jar containing 70% EtOH for 10 min at RT.  
 
After 10 min of incubation in 70% EtOH, the coverslips were incubated in RNA removal solution 
(10 ml 70% EtOH + 200 μl 10M NaOH) for 5 min at RT. Coverslips were then washed 3 times 
with 70% EtOH, and then incubated for 5 min in 70% EtOH and in 100% EtOH for another 5 
min. The coverslips were then briefly air dried prior to denaturation at 800C for 2.5 min in a 
buffer containing 7 ml Formamide, 2 ml H2O, 1 ml 20 x SSC; pH adjusted between 7.1 and 7.4 
with HCl, pre-heated in coplin jar to 800C. After denaturation, coverslips were incubated for 5 
min in ice-cold 70% EtOH and then for 5 min in ice-cold 100% EtOH.  
 
DNA hybridization mixtures contained: 3 μl Cot-1 DNA (1 μg/μl), 2 μl salmon sperm (Invitrogen, 
D9156) and added tRNA (10 mg/ml), and 1-5 μl of Bioprime labelled FISH DNA Probe (100 
ng/coverslip). These mixtures were assembled in 1.5 ml eppendorf tubes on ice and placed into 
a Speed-Vac for 20 minutes – 1 hour until the liquid completely dried. The DNA was 
resuspended with 10 μl formamide (Sigma-Aldrich 221198), vortexed and spun at 16,000 x g for 
1 min. The samples were heated to 80°C for 10 min and 10 μl of hybridization buffer was added 
to the tube. This hybridization cocktail was transferred to parafilm on a glass support. The 
coverslips were briefly air dried, inverted onto the hybridization cocktail and covered with 
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parafilm. Coverslips were then incubated O/N at 370C in a humidified chamber. After incubation, 
samples were washed first with 5 ml formamide + 5 ml 4X SSC for 20 min at 37°C in a humid 
chamber; then with 2X SSC for 20 min in 37° C humid chamber; and with 1X SSC, at RT in a 
shaker for 20 min. Coverslips were incubated with 4X SSC at RT for 1 min.  Fluorescently-
labeled Streptavidin (594 or 488) was diluted 1:500 in 4X SSC / 1%BSA and coverslips were 
incubated with this at 37°C for 1 hour. The incubation was followed by three washes perfomed 
in the dark: 4X SSC at RT in a shaker for 10 min; 4X SSC / 0.1% Triton at RT in a shaker for 10 
min; and with 4X SSC at RT in a shaker for 10 min. 
 
Coverslips were then incubated in PBS for 5 min. For immunocytochemistry, samples were 
blocked in 1X PBS/ 1% BSA for 15-30 min at RT. Primary antibodies were diluted in blocking 
solution and samples were incubated O/N at 40C. Samples were washed with PBS and 
incubated with secondary antibodies for 1 h at 37 0C.  Coverslips were washed with PBS, 1X 
PBS / 0.1% TritonX-100, and 1xPBS at RT on a shaker, 10 min each.  Finally, the coverslips 
were rinsed twice with PBS and one time with water, and mounted using Prolong Gold antifade 
reagent (Invitrogen, cat#P36934). 
 
Images were acquired with a Zeiss Axiovert 200M, a Perkin Elmer Ultraview spinning disc 
microscope and Hamamatsu ORCA-ER camera. (100x NA1.4 Plan-Apocromat Oil objective). 
DNA-FISH probes were counted through Z-stacks manually, and were scored as “associated” 
when no detectable gap between nucleolar marker and labeled probe was detected throughout 
the Z-stack. Each probe was analyzed in at least three biological replicates, with about 100 
alleles counted per each replicate. For images, fluorescence range intensity was adjusted 
identically for each series of panels. Z stacks are shown as 2D maximum projections or as a 
single optical section (MetaMorph, Molecular Devices). All statistical analysis was done using 
GraphPad Prism software.  
 
Fluorescence intensities were quantified from the sum of Z-stacks using an adaptation of 
previously described methods (Delaval et al. 2011). Intensities in concentric circles of 408 μm2 
(inner area) and 816 μm2 (outer area) were measured. Inner area circles were placed around 
nuclei so that the borders of the nucleus did not go beyond the area. Nuclear signal intensity 
was calculated using formula: I=E5-((E6-E5)*(C5/(C6-C5)), where I is nuclear intensity; E5 is an 
integrated signal intensity of inner circle; E6 is an integrated signal intensity of outer circle; C5 is 
the area of inner circle, C6 is the area of outer circle. In this manner, local background was 
calculated as the signal in the outer area minus the signal in the inner area, and the signal in 
each nucleus was the inner signal minus the local background.  
 
Data access 
All sequencing data and quality control information for individual samples is publically available 
at the NIH 4DN Data Portal (data.4dnucleome.org) under accession 
numbers 4DNES15QV1OO, 4DNES8D85R8H, 4DNESR3K7VRN, 4DNES4U7AY3P, 
4DNESNEBF9W4, 4DNES7SVJXAI. See Supplemental Table S1 for details. 
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Figure Legends  
 
 
Figure 1. Identification of mouse nucleolus-associated domains (NADs). 
 
A. A schematic workflow of nucleolar isolation. Details that differ between the crosslinked 
and non-crosslinked versions of the preparation are illustrated in Supplemental Figure 
S1.  
B. Comparison of NADs to heterochromatin features, and analysis of NAD-seq by multiple 
bioinformatic packages, including NADfinder. All data shown are from MEF cells. In this 
panel, the strongly nucleolar-associated chromosome 19 is shown in its entirety. Tracks 
shown from the top are DNA Replication timing data (Hiratani et al. 2010)(early 
replicating regions have positive values) and LADs (red, (Peric-Hupkes et al. 2010)). 
Below those are raw sequence data from crosslinked cells (blue, experiment #26): read 
counts for total genomic DNA (Genomic), nucleolar-associated DNA (Nucleolar), and the 
Nucleolar/Genomic ratio. Next are shown comparisons of peaks called by the 
bioinformatic packages MACS (broad peaks setting), EDD (50K bins), Hidden Domains 
(50K bins), and normr (50K bins, v1<0.01, q<10e-03). At the bottom are peaks called by 
NADfinder (default cutoff q<0.05). All software tested except NADfinder called almost the 
entire chromosome as peaks. NADs called by NADfinder generally correlate with LADs 
and late replication timing. 
C. As in Figure 1B, showing chromosome 5. Note the gradual decrease in the ratio going 
from left to right (away from the centromere on the left of this acrocentric chromosome). 
Unlike MACs and EDD, NADfinder was able to call peaks on regions distal from the 
centromere. 
 
Figure 2. Distinct classes of mouse NADs. 
 
A. Subdivision of MEF NADs based on overlap with LAD or ciLAD regions. chr17 is shown. 
Features associated with heterochromatin (H3K9me2, lamin association, and late 
replication timing) are colored in red, while features associated with euchromatin (early 
replication timing and ciLAD regions) are in cyan. At the top is shown DNA replication 
timing (Hiratani et al. 2010), followed by H3K9me2 (from MEF cells lacking 
methyltransferase G9a, making heterochromatic H3K9me2 more easily visualized 
(GSM2803100)(Chen et al. 2018)). Next are constitutive LAD and MEF LAD peaks 
(Peric-Hupkes et al. 2010; Meuleman et al. 2013). Following those are eight tracks of 
NAD data, the top four from a crosslinked preparation (XL experiment #26), and the 
bottom four from a non-crosslinked preparation (nonXL experiment #29). At the top of 
each set is the log2 ratio of nucleolar/genomic sequencing reads, followed by the peaks 
determined by NADfinder (blue). These are followed by a pair of tracks in which the NAD 
peaks were separated at the nucleotide level into regions that overlap the MEF LADs 
(magenta) and regions that overlap ciLADs (light green). The bottom two tracks are 
ciLADs in cyan (Peric-Hupkes et al. 2010; Meuleman et al. 2013), and H3K27me3 in 
olive green ((GSM2417097)(Chronis et al. 2017)). 
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B. Venn diagram illustrating the overlap among NADs, LADs and ciLAD regions. Data from 
non-crosslinked experiments are on the left, and crosslinked ones are on the right. 
Numbers show the size of the indicated regions, in Mb. 
C. Venn diagram illustrating overlap of XL and nonXL NAD peaks. Numbers indicate size of 
each region in Mb, which are drawn proportional to size. 
D. Boxplot distributions of NAD lengths, showing median and quartiles in the box.  
 
 
Figure 3. 3-D DNA-FISH experiments confirm nucleolar association of NADs. 
 
A. Maximum projection of confocal microscopy images from a 3-D immunoFISH experiment 
(pPK871 BAC DNA probe, red; fibrillarin, green; DAPI, blue; scale bar 10μm).  
B. As in panel A, with pPK828 as the DNA probe. 
C. As in panel A, with pPK914 as the DNA probe. 
D. Graph of percentage of alleles that are associated with nucleolus (mean ± SEM for n > 3 
biological replicate experiments). Negative probes (blue) display nucleolar association 
that is not significantly different than the negative probe pPK871 (p > 0.05, Welch’s t-
test). In contrast, all type I (red) and type II (green) probes display association 
significantly different from pPK871 (p < 0.03).  
E. Data for nucleolar association from panel D were grouped (see coloration). p values for 
the differences between the different groups are shown. 
F. Graph comparing the % nucleolar-associated alleles from DNA-FISH (y-axis) vs the 
adjusted p-value (x-axis) of the nonXL NAD peaks identified by NADfinder that overlap 
with the indicated BAC probe. Note that the “negative” probes (blue) have an adj.p-value 
= 1 = 10e0. 
G. As in panel F except that x-axis is the adjusted p-value of the XL NAD peaks. Note that 
the “negative” probes (blue) have an adj.p-value > 10e-3. 
H. Single optical sections of confocal microscopy images of a 3-D immunoFISH 
experiment. pPK834 BAC DNA probe hybridizing to a type I NAD, green; fibrillarin, red; 
nuclear pore protein Nup62, blue; scale bar 10 μm.  
I. As in panel C, with pPK828 as the DNA probe hybridizing a type II NAD. 
J. Graph of percentage of alleles that are associated with nuclear periphery (mean ± SEM 
for n > 3 biological replicate experiments). Only Type I NAD probe pPK834 (*) displays 
laminar association that is significantly different than the negative control pPK871 (p = 
0.042, Welch’s t-test). As expected, three Type II NAD probes (pPK828, 914 and 915) 
do not display significant laminar association.  
 
Figure 4. Differential chromatin states and gene density and expression in different 
classes of NADs. 
A. Gene densities of the indicated genomic regions are shown, ranked left to right.   
B. Distribution of gene expression levels from RNAseq data, expressed as FPKM for the 
same genomic regions analyzed in panel A.  
C. Venn diagram analysis of the overlap among NADs (nonXL), LADs and H3K9me3 
peaks. Numbers indicate size of each region in Mb, which are drawn proportional to size.  
D. As in panel C, except that the overlaps with LADs and H3K27me3 peaks are shown.  
E. As in panel C, except that the overlaps with ciLADs and H3K9me3 are shown. 
F. As in panel C, except that the overlaps with ciLADs and H3K27me3 are shown. 
G. Venn diagram analysis of overlaps with DNA replication timing (RT) data and LADs. As 
in panels C-F, nonXL NAD data are analyzed, except that in place of histone 
modifications, overlaps with regions of early RT are indicated. For simplicity, only the 
numbers (Mb) for the overlap between the NADs and the RT data are shown. The 
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numbers here are smaller than those in panels C-F because the RT data is based on 
short microarray probes rather than deep sequencing.  
H. As in panel G, except that overlaps with ciLADs and early RT are shown. 
I. As in panel G, except that overlaps with LADs and late RT are shown. 
J. As in panel G, except that overlaps with ciLADs and late RT are shown. 
 
 
Fig. 5. Inhibition of H3K27 methylation blocks NAD localization 
A. Immunofluorescence measurement of H3K27me3 levels in control cells.  
B. As in panel K, except cells were treated with GSK126. 
C. As in panel K, except cells were treated with EPZ6438. 
D. Quantitation of IF data from panels A-C. GSK126, ****: p < 0.0001, Welch’s t-test. 
EPZ6438, ****: p < 0.0001, Welch’s t-test. 
E. Immunoblot analyses of cells treated as in panels A-C. 
F. 3D immuno-FISH localization of type I probe pPK834 (green), anti-nucleophosmin 
antibodies (NPM (ab10530, Abcam), red), and anti-LaminA antibodies (blue). Untreated 
control cells. 
G. As in Panel F, except that cells were treated with GSK126.  
H. As above, except that cells were treated with EPZ6438.  
I. Quantitation of pPK834 nucleolar association measured by DNA FISH as in Figure 3. 
GSK126, *: p = 0.040, Welch’s t-test. EPZ6438, *: p = 0.023, Welch’s t-test. 
J. Quantitation of pPK834 laminar association measured by DNA FISH as in Figure 3. 
GSK126, **: p = 0.0029, Welch’s t-test. EPZ6438, *: p = 0.021, Welch’s t-test. 
K. 3D immuno-FISH localization of type II probe pPK828 (green), with other markers as in 
Panel A. Untreated control cells.  
L. As in Panel K, except that cells were treated with GSK126. 
M. As above, except that cells were treated with EPZ6438. 
N. Quantitation of pPK828 nucleolar association. GSK126, p = 0.083, Welch’s t-test. 
EPZ6438, *: p = 0.018, Welch’s t-test. 
O. Quantitation of pPK828 laminar association. GSK126, p = 0.33, Welch’s t-test. EPZ6438, *: 
p = 0.63, Welch’s t-test. 
P. Immunofluorescence analysis of H3K9me3 distribution in untreated control cells. 
Q. As in panel P, treated with media containing 1% 1,6-hexanediol for 2 hours. 
R. Quantification of pPK828 nucleolar association in control and hexanediol-treated cells. 1% 
hex **: p = 0.0090, Welch’s t-test. 
 
Figure 6. Type II NADs contain developmentally regulated genes and can be differentially 
localized in MEF and ES cells. 
 
A. GO enrichment analysis of type II NADs (nonXL). In this panel, the 7 most significant 
Biological Processes annotations and q values are shown.  
B. As in panel A, showing the Cell Components annotations. 
C. As in panel A, showing the Molecular Functions annotations. 
D. Analysis of specific loci, using the same IGV session as in Figure 2, except that tracks 
showing NADfinder-derived zscores are also included. Genomic region showing two 
Type II NAD peaks (the one on the right achieved a statistical significance of q<10e-3 
only in the XL but not nonXL data). The peak on the left contains the Pax2 transcription 
factor gene. The peak on the right contains the Tlx1 and Lbx1 homeobox transcription 
factor genes.  
E. As in panel D, showing a Type II peak containing the Grik3 glutamate receptor gene. 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/484568doi: bioRxiv preprint first posted online Dec. 3, 2018; 
	 27 
F. Single optical sections of confocal microscopy images of 3-D FISH analysis of mouse D3 
embryonic stem cells. BAC DNA probes are labeled in red, fibrillarin in green, scale bar 
10μm. In MEFs, pPK871 is a negative control probe, pPK828 is a Type II NAD, and 
pPK834 is a Type I NAD (see Fig. 3). 
G. Quantification of D3 mES cell FISH. Graph, left: percentage of alleles from the indicated 
probes associated with nucleoli (mean ± SEM). Welch’s t-tests for difference from 
pPK871: ** pPK834 (p = 0.0018), pPK828 (p = 0.62). 
H. A diagram that summarizes the distinct characteristics of Type I and II NADs. 
 
 
 
Supplemental Figure S1. Isolation and characterization of purified nucleoli.  
A. Schematic representation of crosslinked and non-crosslinked methods used for isolation 
of nucleoli. The abbreviations of the fractions analyzed by immunoblotting in panel D are 
indicated.  
B. Phase microscopy images of nucleoli purified via crosslinked (experiment #24, see 
Supplemental Table S1) and non-crosslinked (experiment #29) methods (20x 
magnification, scale bar 10 µm).   
C. qPCR analyses of rDNA enrichment in purified nucleoli compared to genomic DNA. We 
observed 30-50-fold rDNA enrichment in purified non-crosslinked nucleoli (experiment 
#33), depending on the primer set used. An 8-13-fold enrichment was observed in 
crosslinked samples (mean values for experiments #24, 26, 28).  
D. Immunoblot analyses of crosslinked and non-crosslinked preparations. Fibrillarin was 
used as a nucleolar (nus) marker. Nuclear periphery proteins (porin Nup62 and 
LaminA/C) were present in total (tot) and crude nuclear (nuc, S1) extracts, but depleted 
from nucleolar (nus) fractions. Cytoskeletal protein actin was enriched in total and crude 
cytosolic (cyt, S1) fractions, but not in nucleoplasmic (np) or nucleolar (nus) fractions. 
E. Analysis of RNAs from fractions obtained during a non-crosslinked preparation. The 
nucleolar-specific small RNA U3 (Politz et al. 2009) as well as the ribosomal 5S species 
are illustrated.  
 
 
Supplemental Figure S2. Analysis of raw data from biological replicate samples.  
In addition to DNA replication timing (early replicating regions in cyan, late in red, (Hiratani et al. 
2010)) and LAD (Peric-Hupkes et al. 2010) data from MEFs at the top, we display the raw 
sequencing reads from purified nucleoli from each of six biological replicate experiments. Three 
samples were made using the crosslinked protocol (XL), and three were non-crosslinked 
(nonXL). 
 A. Chromosome 19. 
 B. Chromosome 4. 
 C. Pearson correlations of log2 (Nucleolus/Genomic) ratio of all 6 experimental samples 
were calculated. Crosslinked (XL) and non-crosslinked (nonXL) samples are indicated.  
 
Supplemental Figure S3. Additional comparisons of different bioinformatic analyses of 
NAD-seq data.  
A. Chromosome 4 is shown in its entirety. In addition to the tracks shown in Figure 1B-C, 
we compared additional settings for each bioinformatics program tested. For MACS, 
we compared the broad peak, and narrow peak settings (Zhang et al. 2008; Feng et 
al. 2012). For EDD, we compared 50 Kb binning with and without filtering at a 0.975 
confidence threshold (Lund et al. 2014). For Hidden Domains, we compared binning 
at 5, 10, and 50 Kb (Starmer and Magnuson 2016). For normr, we compared binning 
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at 10 and 50 Kb (Kinkley et al. 2016; Helmuth et al. 2016). As observed for chr5 (Fig. 
1C), unlike MACS and EDD, NADfinder was capable of identifying peaks in the 
region distal from the centromere (on the right). 
B. As in panel A, showing a region of chrXqE. Note the flat level of nucleolar enrichment 
across this region. The red bar at the top is probe pPK831, a BAC that was observed 
to be negative for nucleolar association in DNA-FISH experiments (see Fig. 2). This 
region was correctly called negative by NADfinder, but incorrectly identified as 
positive by EDD, Hidden Domains, and normr.  
C. As in panel A, showing a distal telomere-proximal region of chr7, including the Kcnq1 
locus. This locus has previously been shown to associate with nucleoli (Pandey et al. 
2008; Fedoriw et al. 2012a). Of the bioinformatics programs used, only NADfinder 
correctly called this locus as a peak. 
 
Supplemental Figure S4. Testing baseline correction and sequencing depth requirements 
for NADfinder. 
A. Workflow of NAD-seq analysis using NADFinder and ChIPpeakAnno. 
B. Chromosome-level baseline correction is necessary for optimal peak calling by 
NADfinder, shown for chr11. Without baseline correction, peaks at the distal region of 
the chr11 are missed. Replication timing and LAD peak data from MEFs are shown as in 
Fig. 1. Blue tracks show nucleolar/genomic ratios from crosslinked (XL) and non-
crosslinked (nonXL) preparations, with NADfinder peaks also in blue. Green tracks show 
peaks called by NADfinder without baseline correction. 
C. As in panel B, chr12 is shown. Same as chr11, without baseline correction, peaks at the 
distal region of the chr12 are missed. 
D. Subsampling analysis with peak calling at 5% false discovery rate. In this 
experiment, about 200 million reads per library were obtained for 2 pairs of genomic and 
nucleolar samples. This analysis suggests that 25% of subsampling rate resulting in 
about 50 million reads, would identify similar sets of peaks at 5% discovery rate as the 
whole dataset, i.e. 200 million reads. 
E. Receiver operating characteristic curves (ROC) show that a 20% subsampling rate 
results in similar ROC as observed using the entire 200 million read dataset in panel D. 
  
Supplemental Figure S5. Genomic locations of BACs used for FISH experiments.  BAC 
locations are shown as red horizontal bars at the top of each graph. 
A. The same IGV session used in Figure 6 is used here to show a region of the chr12qF 
locus that contains three BAC probes used in these studies. Left to right, pPK871 
(negative control, no NAD enrichment), pPK828 (Type II NAD, overlapping ciLAD but not 
LAD regions), and pPK827 (Type I NAD, overlapping LAD but not ciLAD regions). 
B. pPK914. This Type II NAD contains ion channel genes (Kcnj6, Kcnj15) as well as 
developmentally regulated Ets-family transcription factors (Erg, Ets2). The Type II NAD 
to the left overlaps the Sim2 gene encoding a developmentally-regulated, single-minded 
family bHLH transcription factor. 
C. pPK915. This Type II NAD contains a cluster of cation transporter genes (Slc22a1,2,3).  
 
 
Supplemental Figure S6. Examples of Type II NADs carrying genes with enriched GO 
annotations.   
A. The same IGV session used in Figure 6 is used here to show a region including the NAD 
encompassing the gene encoding developmental transcription factor Sox1 (which is very 
small and located within the Gm5607 locus). 
B. This Type II NAD contains the gene encoding the Fibroblast growth factor 1 (Fgf1) gene. 
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C. There are two Type II NADs shown here. On the left is one containing the Scn8a gene 
encoding a sodium channel. On the right is a NAD containing a cluster of keratin (Krt) 
genes.  
 
 
Supplemental Table 1 
Sequencing depth/mapping statistics for replicate experiments 
 
Supplemental Table 2 
GO term analyses of Type II NADs, showing annotations with q< 0.05 
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